BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17502781)

  • 1. Aripiprazole augmentation for treatment-resistant bipolar depression: sustained remission after 36 months.
    Kemp DE; Dago PL; Straus JL; Fleck J; Karaffa M; Gilmer WS
    J Clin Psychopharmacol; 2007 Jun; 27(3):304-5. PubMed ID: 17502781
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement in intractable tardive dystonia in bipolar disorder after aripiprazole treatment: a case report.
    Takagai S; Nakasato K; Suzuki K; Kasai E; Isogai S; Morimoto S; Mori N
    J Clin Psychopharmacol; 2012 Aug; 32(4):563-4. PubMed ID: 22760347
    [No Abstract]   [Full Text] [Related]  

  • 3. Open-label aripiprazole in the treatment of acute bipolar depression: a prospective pilot trial.
    McElroy SL; Suppes T; Frye MA; Altshuler LL; Stanford K; Martens B; Leverich GS; Post RM; Keck PE
    J Affect Disord; 2007 Aug; 101(1-3):275-81. PubMed ID: 17229469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.
    Goforth HW; Carroll BT
    J Clin Psychopharmacol; 2007 Apr; 27(2):216-7. PubMed ID: 17414252
    [No Abstract]   [Full Text] [Related]  

  • 5. Aripiprazole and depression in schizoaffective disorder.
    Errico JR; Yates WR
    Am J Psychiatry; 2005 Mar; 162(3):626-7. PubMed ID: 15741489
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
    Yatham LN
    J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression.
    Dunn RT; Stan VA; Chriki LS; Filkowski MM; Ghaemi SN
    J Affect Disord; 2008 Sep; 110(1-2):70-4. PubMed ID: 18272230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients.
    Mazza M; Squillacioti MR; Pecora RD; Janiri L; Bria P
    Psychiatry Res; 2009 Jan; 165(1-2):193-6. PubMed ID: 18973955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole in a patient susceptible to urinary side effects of antipsychotics.
    Sahoo S
    Isr J Psychiatry Relat Sci; 2007; 44(1):74-5. PubMed ID: 17668467
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of a clozapine-aripiprazole combination in Tourette syndrome and bipolar spectrum disorder.
    Piccinni A; Veltri A; Marazziti D; Moroni I; Dell'Osso L
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):E45. PubMed ID: 23487230
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term (prophylactic) therapy of bipolar patients with aripiprazole].
    Kovács G
    Neuropsychopharmacol Hung; 2010 Jun; 12(2):369-72. PubMed ID: 20606246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Criteria for defining symptomatic and sustained remission in bipolar I disorder: a post-hoc analysis of a 26-week aripiprazole study (study CN138-010).
    Masand PS; Eudicone J; Pikalov A; McQuade RD; Marcus RN; Vester-Blokland E; Carlson BX
    Psychopharmacol Bull; 2008; 41(2):12-23. PubMed ID: 18668014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole in refractory depression?
    Carroll BJ
    J Clin Psychopharmacol; 2009 Feb; 29(1):90-1; author reply 92-3. PubMed ID: 19142117
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole for acute bipolar mania.
    Jagadheesan K; Muirhead D
    Am J Psychiatry; 2004 Oct; 161(10):1926-7. PubMed ID: 15465998
    [No Abstract]   [Full Text] [Related]  

  • 15. Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
    McIntyre RS
    Clin Ther; 2010; 32 Suppl 1():S32-8. PubMed ID: 20152551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder.
    Uguz F
    Gen Hosp Psychiatry; 2010; 32(5):556-8. PubMed ID: 20851277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole in the treatment of bipolar disorder in children and adolescents.
    Durkin JP
    J Child Adolesc Psychopharmacol; 2004; 14(4):505-6. PubMed ID: 15662141
    [No Abstract]   [Full Text] [Related]  

  • 18. Aripiprazole: a clinical review of its use for the treatment of anxiety disorders and anxiety as a comorbidity in mental illness.
    Katzman MA
    J Affect Disord; 2011 Jan; 128 Suppl 1():S11-20. PubMed ID: 21220076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
    Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
    J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjunctive aripiprazole in treatment-resistant bipolar depression.
    Ketter TA; Wang PW; Chandler RA; Culver JL; Alarcon AM
    Ann Clin Psychiatry; 2006; 18(3):169-72. PubMed ID: 16923655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.